Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hepatic antioxidant defense system is a complex network of enzymatic and non-enzymatic components designed to protect the liver from oxidative damage caused by reactive oxygen species (ROS) and reactive nitrogen species (RNS) [1, 9]. Key enzymatic members include superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), while non-enzymatic components include reduced glutathione (GSH), vitamin C, and vitamin E [1, 2]. This system is primarily regulated by the transcription factor Nrf2, which orchestrates the expression of cytoprotective genes in response to oxidative stress [9, 11]. In various liver diseases, such as metabolic dysfunction-associated steatotic liver disease (MASLD), alcoholic liver disease, and viral hepatitis, the balance between ROS production and antioxidant capacity is disrupted, leading to lipid peroxidation, protein oxidation, and DNA damage [9, 16]. Therapeutic strategies often aim to bolster this system through the administration of exogenous antioxidants like N-acetylcysteine or the use of Nrf2 activators to induce endogenous enzyme production [5, 18]. However, clinical translation has been challenging, as excessive antioxidant supplementation can sometimes interfere with essential ROS-mediated signaling pathways or exhibit pro-oxidant effects [18]. Understanding the spatial and temporal regulation of these defenses remains critical for developing effective hepatoprotective therapies [12].
Activation of the Nrf2-ARE pathway to induce antioxidant enzyme expression, direct scavenging of reactive oxygen species, and replenishment of endogenous antioxidant pools like glutathione [9, 11].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatic antioxidant defense system.